Sixth, it clarifies why CpG>TpG mutations are enriched in regions with lower activity of MMR, such as late-replicating regions, and why this relationship is lost in cancers deficient in MMR (Fig. 6b,c). This evidence concerns the gene MRC1 and cancer.